RxDoctor Payments Data

Paolo Angelini

Interventional Cardiology · Houston, TXNPI 1114947645

Payments from drug & device makers

$7,129in general payments, 2019–2025

Across 406 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Amgen$825
  • Novartis$659
  • Sanofi-aventis U.S. LLC$422
  • Kowa Pharmaceuticals America, Inc.$414
  • Boston Scientific$406
  • plus $3K from 25 others

What the payments were for

  • Food & beverage$7,121100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,129 in reported general payments places this provider in the 35th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas

Other interventional cardiology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →